681 related articles for article (PubMed ID: 34361100)
1. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses.
Jan A; Gonçalves NP; Vaegter CB; Jensen PH; Ferreira N
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361100
[TBL] [Abstract][Full Text] [Related]
2. The prion hypothesis of Parkinson's disease.
Chu Y; Kordower JH
Curr Neurol Neurosci Rep; 2015 May; 15(5):28. PubMed ID: 25868519
[TBL] [Abstract][Full Text] [Related]
3. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
Brás IC; Outeiro TF
Cells; 2021 Feb; 10(2):. PubMed ID: 33673034
[TBL] [Abstract][Full Text] [Related]
4. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
Vargas JY; Grudina C; Zurzolo C
Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
[TBL] [Abstract][Full Text] [Related]
5. [Prion Properties of Alpha-Synuclein].
Schwarzman AL; Senkevich KA; Emelyanov AK; Pchelina SN
Mol Biol (Mosk); 2019; 53(3):380-387. PubMed ID: 31184602
[TBL] [Abstract][Full Text] [Related]
6. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease.
Pan L; Li C; Meng L; Tian Y; He M; Yuan X; Zhang G; Zhang Z; Xiong J; Chen G; Zhang Z
Brain; 2022 Oct; 145(10):3454-3471. PubMed ID: 35552614
[TBL] [Abstract][Full Text] [Related]
7. Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.
Luna E; Luk KC
FEBS Lett; 2015 Dec; 589(24 Pt A):3749-59. PubMed ID: 26505673
[TBL] [Abstract][Full Text] [Related]
8. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
Benskey MJ; Perez RG; Manfredsson FP
J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?
Lema Tomé CM; Tyson T; Rey NL; Grathwohl S; Britschgi M; Brundin P
Mol Neurobiol; 2013 Apr; 47(2):561-74. PubMed ID: 22544647
[TBL] [Abstract][Full Text] [Related]
10. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
[TBL] [Abstract][Full Text] [Related]
11. Propagation of Distinct α-Synuclein Strains Within Human Reconstructed Neuronal Network and Associated Neuronal Dysfunctions.
Gribaudo S; Bousset L; Courte J; Melki R; Peyrin JM; Perrier AL
Methods Mol Biol; 2023; 2551():357-378. PubMed ID: 36310215
[TBL] [Abstract][Full Text] [Related]
12. What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
Dunning CJ; George S; Brundin P
Prion; 2013; 7(1):92-7. PubMed ID: 23360753
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
[TBL] [Abstract][Full Text] [Related]
14. The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson's disease.
Meng L; Liu C; Li Y; Chen G; Xiong M; Yu T; Pan L; Zhang X; Zhou L; Guo T; Yuan X; Liu C; Zhang Z; Zhang Z
Sci Adv; 2023 Nov; 9(44):eadj1092. PubMed ID: 37910610
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease as a member of Prion-like disorders.
Herva ME; Spillantini MG
Virus Res; 2015 Sep; 207():38-46. PubMed ID: 25456401
[TBL] [Abstract][Full Text] [Related]
16. The misfolding mystery: α-synuclein and the pathogenesis of Parkinson's disease.
Negi S; Khurana N; Duggal N
Neurochem Int; 2024 Jul; 177():105760. PubMed ID: 38723900
[TBL] [Abstract][Full Text] [Related]
17. Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents.
Sato H; Kato T; Arawaka S
Mol Neurobiol; 2015 Aug; 52(1):226-35. PubMed ID: 25143237
[TBL] [Abstract][Full Text] [Related]
18. α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice.
Butler YR; Liu Y; Kumbhar R; Zhao P; Gadhave K; Wang N; Li Y; Mao X; Wang W
Nat Commun; 2022 Jul; 13(1):4060. PubMed ID: 35853942
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein in Parkinson's Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role?
Zheng H; Shi C; Luo H; Fan L; Yang Z; Hu X; Zhang Z; Zhang S; Hu Z; Fan Y; Yang J; Mao C; Xu Y
Neuroscientist; 2021 Aug; 27(4):367-387. PubMed ID: 32729773
[TBL] [Abstract][Full Text] [Related]
20. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
Xu S; Chan P
Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
